论文部分内容阅读
肝素是目前临床上应用相对广泛的抗凝药物,低分子肝素钙是从肝素中分离或降解而来,目前临床上应用更加广泛。肝素诱导的血小板减少症(heparin-induced thrombocytopenia,HIT)是应用肝素后严重的不良反应。国内有关HIT的文献报道较少,且多局限于综述。现将本院2014年出现的2例HIT报道如下,旨在提高对这种不良反应的认识。1临床资料病例1:患者,男,67岁,既往体健。因“外伤致胸腹痛7
Heparin is currently widely used in clinical anticoagulant drugs, low molecular weight heparin from heparin separation or degradation from the clinical application of the more widely. Heparin-induced thrombocytopenia (HIT) is a serious adverse reaction after heparin is applied. Domestic literature on HIT less reported, and more limited to the review. Two HIT cases now appearing in our hospital in 2014 are reported below to raise awareness of this adverse reaction. 1 clinical data Case 1: patients, male, 67 years old, previous physical health. Because of ”trauma caused chest pain 7